Brivaracetam, plasma

Alphabetical Test listing

Brivaracetam, plasma-994

  
Brivaracetam, plasma
  
994
  
LAB994
  
MSO
  
Briviact
  

Therapeutic drug monitoring (TDM)

  
EDTA plasma
  
  
1.0 mL
  
0.2 mL
  

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  
  1. Spin
  2. Transfer plasma to a Screw cap transfer via/tube (Mayo T914), labelled as EDTA plasma, within two (2) hours of sample collection
  
  

 

 

  

Refrigerated (preferred) - 30 days

Ambient - 30 days

Frozen - 120 days

  
  • Serum
  • Plasma gel tubes
  
NMS (0718SP) via Mayo Clinic Laboratories (FBRIV): R-NX
  
Daily
  
7 - 9 days
  

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

  

Reporting limit determined each analysis

Units: mcg/mL

 

  
80299
  
No
  
12/14/2018
  
03/09/2023
  
03/08/2023